Essent Group Ltd. (ESNT) stock
ESNTNYSESurety InsuranceFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 10/3015% below fair value
$64.58−0.31 (-0.48%)
Close on Nov 13, 2026Market cap $5.80BP/E 8.8Yield 1.92%
Essent EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Essent's EPS for the twelve months ending Sep 30, 2026 was $7.32, up 6.6% year over year. For fiscal 2025 it was $6.90, up 0.7% from the year before. Over ten years it grew 14.9% a year on average. The highest annual figure on record is $7.72 in fiscal 2022.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.90 | +0.7% |
| FY2024 | Dec 31, 2024 | $6.85 | +5.4% |
| FY2023 | Dec 31, 2023 | $6.50 | -15.8% |
| FY2022 | Dec 31, 2022 | $7.72 | +26.4% |
| FY2021 | Dec 31, 2021 | $6.11 | +57.5% |
| FY2020 | Dec 31, 2020 | $3.88 | -31.4% |
| FY2019 | Dec 31, 2019 | $5.66 | +18.7% |
| FY2018 | Dec 31, 2018 | $4.77 | +19.5% |
| FY2017 | Dec 31, 2017 | $3.99 | +65.6% |
| FY2016 | Dec 31, 2016 | $2.41 | +40.1% |
| FY2015 | Dec 31, 2015 | $1.72 | +67.0% |
| FY2014 | Dec 31, 2014 | $1.03 | +47.1% |
| FY2013 | Dec 31, 2013 | $0.70 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.82 | +9.0% |
| Q2 FY2026 | Jun 30, 2026 | $2.08 | +7.8% |
| Q1 FY2026 | Mar 31, 2026 | $1.82 | +7.7% |
| Q4 FY2025 | Dec 31, 2025 | $1.60 | +1.3% |
| Q3 FY2025 | Sep 30, 2025 | $1.67 | +1.2% |
| Q2 FY2025 | Jun 30, 2025 | $1.93 | +1.0% |
| Q1 FY2025 | Mar 31, 2025 | $1.69 | -0.6% |
| Q4 FY2024 | Dec 31, 2024 | $1.58 | -3.7% |
| Q3 FY2024 | Sep 30, 2024 | $1.65 | -0.6% |
| Q2 FY2024 | Jun 30, 2024 | $1.91 | +18.6% |
| Q1 FY2024 | Mar 31, 2024 | $1.70 | +6.9% |
| Q4 FY2023 | Dec 31, 2023 | $1.64 | +19.7% |
| Q3 FY2023 | Sep 30, 2023 | $1.66 | 0.0% |
| Q2 FY2023 | Jun 30, 2023 | $1.61 | -25.5% |
| Q1 FY2023 | Mar 31, 2023 | $1.59 | -36.9% |
| Q4 FY2022 | Dec 31, 2022 | $1.37 | -17.0% |
| Q3 FY2022 | Sep 30, 2022 | $1.66 | -9.8% |
| Q2 FY2022 | Jun 30, 2022 | $2.16 | +52.1% |
| Q1 FY2022 | Mar 31, 2022 | $2.52 | +108.3% |
| Q4 FY2021 | Dec 31, 2021 | $1.65 | +50.0% |
| Q3 FY2021 | Sep 30, 2021 | $1.84 | +65.8% |
| Q2 FY2021 | Jun 30, 2021 | $1.42 | +846.7% |
| Q1 FY2021 | Mar 31, 2021 | $1.21 | -20.4% |
| Q4 FY2020 | Dec 31, 2020 | $1.10 | -26.2% |
| Q3 FY2020 | Sep 30, 2020 | $1.11 | -24.5% |
| Q2 FY2020 | Jun 30, 2020 | $0.15 | -89.2% |
| Q1 FY2020 | Mar 31, 2020 | $1.52 | +16.9% |
| Q4 FY2019 | Dec 31, 2019 | $1.49 | +13.7% |
| Q3 FY2019 | Sep 30, 2019 | $1.47 | +24.6% |
| Q2 FY2019 | Jun 30, 2019 | $1.39 | +21.9% |
| Q1 FY2019 | Mar 31, 2019 | $1.30 | +15.0% |
| Q4 FY2018 | Dec 31, 2018 | $1.31 | -20.6% |
| Q3 FY2018 | Sep 30, 2018 | $1.18 | +43.9% |
| Q2 FY2018 | Jun 30, 2018 | $1.14 | +48.1% |
| Q1 FY2018 | Mar 31, 2018 | $1.13 | +56.9% |
| Q4 FY2017 | Dec 31, 2017 | $1.65 | +142.6% |
| Q3 FY2017 | Sep 30, 2017 | $0.82 | – |
| Q2 FY2017 | Jun 30, 2017 | $0.77 | – |
| Q1 FY2017 | Mar 31, 2017 | $0.72 | – |
| Q4 FY2016 | Dec 31, 2016 | $0.68 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?